What oncology trials study
Studies may evaluate medicines, combinations, devices, diagnostics, supportive care, digital tools or new ways to organise treatment. Objectives and uncertainty differ by phase and design.
A trial can be scientifically valuable even if an individual participant does not benefit. This distinction must remain clear in communication.
Screening and informed consent
The site first explains the study and obtains informed consent for screening or participation as required. The team then verifies clinical, laboratory and protocol criteria.
A public record cannot replace this process. Questions about alternatives, risks, visits, costs and data use should be answered before a decision.
Rights and safety
Participation is voluntary. A person may decline or withdraw without losing access to ordinary medical care. Safety information is monitored and new relevant information should be communicated during the study.
Quick answers
Frequently asked questions
Is a clinical trial free treatment?
Study-related procedures are governed by the protocol and sponsor arrangements, while ordinary care and local coverage vary. The site should explain costs and responsibilities before consent.
Can my doctor choose a trial from a website?
A website can support discovery. Clinical teams must evaluate medical relevance, alternatives and the protocol.
Evidence base
Primary and authoritative sources
Use the linked source documents for professional or current interpretation.